The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

Research output: Contribution to journalReview article

Abstract

This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

Original languageEnglish (US)
Pages (from-to)561-562+565
JournalP and T
Volume26
Issue number11
StatePublished - Jan 1 2001

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this